Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the rat

Toxicology and Applied Pharmacology

Volumn 165, Issue 1, 2000, Pages 99-105

  Sinton, Christopher M ^a   Fitch, Thomas E ^a   Petty, Frederick ^a,b   Haley, Robert W ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Acetylcholinesterase; Blood brain barrier permeability; Corticosterone; Physostigmine hemisulfate; Pyridostigmine bromide; Restraint stress; Swim stress

Indexed keywords

ACETYLCHOLINESTERASE; CORTICOSTERONE; PYRIDOSTIGMINE; SOMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME ACTIVITY; FORCED SWIMMING TEST; IMMOBILIZATION STRESS; MALE; MEMBRANE PERMEABILITY; NONHUMAN; RAT; SOLDIER; STRESS; TOXICITY TESTING;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0034657512     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.8931     Document Type: Article

References (43)

1. Belova I., Jonsson G. Blood-brain barrier permeability and immobilization stress. Acta Physiol. Scand. 116:1982;21-29.
2. Ben-Nathan D., Lustig S., Danenberg H. D. Stress-induced neuroinvasiveness of a neurovirulent noninvasive sindbis virus in cold or isolation subjected mice. Life Sciences. 48:1991;1493-1500.
3. Berry W. K., Davies D. R. The use of carbamates and atropine in the protection of animals against poisoning by 1,2,3-trimethylpropyl methylphosphonofluoridate. Biochem. Pharmacol. 19:1970;927-934.
4. 14C]-pyridostigmine in the rat. Br. J. Pharmacol. 26:1965;393-402.
5. Borland R. G., Breman D. H., Nicholson A. N. Studies on the possible central and peripheral effects in man of a cholinesterase inhibitor (pyridostigmine). Hum. Toxicol. 4:1985;293-300.
6. Brust P. Blood-brain barrier transport under different physiological and pathophysiological circumstances including ischemia. Exptl. Pathol. 42:1991;213-219.
7. Dirnhuber P., French M. C., Green D. M., Leadbeater L., Stratton J. A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 31:1979;295-299.
8. Dvorska I., Brust P., Hrbas P., Ruhle H. J., Barth T., Ermisch A. On the blood-brain barrier to peptides: effects of immobilization stress on regional blood supply and accumulation of labeled peptides in the rat brain. Endocr. Regul. 26:1992;77-82.
9. Ehrhart-Bornstein M., Bornstein S. R., Trzeclak W. H., Usadel H., Guse-Behling H., Waterman M. R., Scherbaum W. A. Adrenaline stimulates cholesterol side-chain cleavage cytochrome P450 mRNA accumulation in bovine adrenocortical cells. J. Endocrinol. 131:1991;R5-R8.
10. Ellman G. L., Courtney K. D., Anders V. Jr., Featherstone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
11. Friedman A., Kaufer D., Shemer J., Hendler I., Soreq H., Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nature Med. 2:1996;1382-1385.
12. Grubic Z., Sket D., Brzin M. Iso-OMPA-induced potentiation of soman toxicity in rat correlates with the inhibition of plasma carboxylesterases. Arch. Toxicol. 62:1988;398-399.
13. Gupta R. C., Dettbarn W. D. Interaction of cycloheximide and diisopropylphosphoro-fluoridate (DFP) during subchronic administration in the rat. Toxicol. Appl. Pharmacol. 90:1987;52-59.
14. Gupta R. C., Patterson G., Dettbarn W. D. Acute tabun toxicity; biochemical and histochemical consequences in brain and skeletal muscles of rat. Toxicology. 46:1987;329-341.
15. Harris L. W., Lennox W. J., Talbot B. G., Anderson D. R., Swanson D. R. Toxicity of anticholinesterases: interactions of pyridostigmine and physostigmine with soman. Drug Chem. Toxicol. 7:1984;507-526.
16. Iwasaki Y., Wakata N., Kinoshita M. Parkinsonism induced by pyridostigmine. Acta Neurol. Scand. 78:1988;236.
17. Johansson B. B. Blood-brain barrier dysfunction in acute arterial hypertension after papaverine induced vasodilatation. Acta Neurol. Scand. 50:1974;366-372.
18. Johansson B. B. Brain barrier pathology in acute arterial hypertension. Adv. Exptl. Med. Biol. 69:1976;517-527.
19. Johansson B. B., Henning M. 6-Hydroxydopamine and blood-brain barrier in adult conscious rats. Acta Physiol. Scand. 110:1980;1-4.
20. Keeler J. R., Hurst C. G., Dunn M. A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA. 266:1991;693-695.
21. Lallement G., Foquin A., Baubichon D., Burckhart M.-F., Carpentier P., Canini F. Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea-pigs. Neurotoxicology. 19:1998;759-766.
22. Lennox W. J., Harris L. W., Talbot B. G., Anderson D. R. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sci. 37:1985;793-798.
23. Liu J. Y., Diaz T. G., Vadgama J. V., Henry J. P. Tail sectioning: a rapid and simple method for repeated blood sampling of the rat for corticosterone determination. Lab. Animal Sci. 46:1996;243-245.
24. Matthew C. B., Hubbard R. W., Francesconi R. P. A heat-stressed rat model to determine relative anticholinergic and anticholinesterase drug potency. Aviat. Space Environ. Med. 57:1986;1061-1065.
25. Maxwell D. M., Brecht K. M., O'Neill B. L. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol. Lett. 39:1987;35-42.
26. Melia K. R., Ryabinin A. E., Schroeder R., Bloom F. E., Wilson M. C. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J. Neurosci. 14:1994;5929-5938.
27. Minagawa T., Kohno Y., Suwa T., Tsuji A. Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterases. Biochem. Pharmacol. 49:1995;1361-1365.
28. Myers D. K. Studies on cholinesterase. 9. Species variation in the specificity patterns of the pseudo-cholinesterase. Biochem. J. 55:1953;67-69.
29. Nozawa M., Tanizawa K., Kanaoka Y. New chromogenic substrates for the determination of butyrylcholinesterase and arylesterase activities. J. Pharmacobiodyn. 3:1980;321-327.
30. Olsson Y., Crowell R. M., Klatzo J. The blood-brain barrier to protein tracers in focal cerebral ischemia and infarction caused by occlusion of the middle cerebral artery. Acta Neuropath. (Berl.). 18:1971;89-102.
31. Petito C. K., Schaefer J. A., Plum F. Ultrastructural characteristics of the brain and blood-brain barrier in experimental seizures. Brain Res. 127:1977;251-267.
32. Sharabi Y., Danon Y. L., Berkenstadt H., Almog S., Mimouni-Bloch A., Zisman A., Dani S., Atsmon J. Survey of symptoms following intake of pyridostigmine during the Persian Gulf War. Israel J. Med. Sci. 27:1991;656-658.
33. Sharma H. S., Cervos-Navarro J., Dey P. K. Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci. Res. 10:1991;211-221.
34. Sharma H. S., Dey P. K. Probable involvement of 5-hydroxytryptamine in increased permeability of blood-brain barrier under heat stress in young rats. Neuropharmacology. 25:1986;161-167.
35. Sharma H. S., Dey P. K. EEG changes following increased blood-brain barrier permeability under long-term immobilization stress in young rats. Neurosci. Res. 5:1988;224-239.
36. Sharma H. S., Nyberg F., Cervos-Navarro J., Dey P. K. Histamine modulates heat stress-induced changes in blood-brain barrier permeability, cerebral blood flow, brain oedema and serotonin levels: an experimental study in conscious young rats. Neuroscience. 50:1992;445-454.
37. Sharma H. S., Westman J., Navarro J. C., Dey P. K., Nyberg F. Probable involvement of serotonin in the increased permeability of the blood-brain barrier by forced swimming. An experimental study using Evans blue and 131I-sodium tracers in the rat. Behav. Brain Res. 72:1995;189-196.
38. Sidell F. R., Borak J. Chemical warfare agents: II. Nerve Agents. Ann. Emerg. Med. 21:1992;865-871.
39. Taylor, P. 1990, Anticholinesterase agents. In, The Pharmacological Basis of Therapeutics, 8th ed. (, A. G. Gilman, T. W. Rall, A. S. Nies and P. Taylor, Eds.), pp, 131, - 147, McGraw Hill, New York.
40. Telang F. W., Ding Y. S., Volkow N. D., Molina P. E., Gatley S. J. Letter to the editor. Nuc. Med. Biol. 26:1999;249-250.
41. Van Deurs B. Observations on the blood-brain barrier in hypertensive rats, with particular reference to phagocytic pericytes. J. Ultrastruct. Res. 56:1976;65-77.
42. Wijsman J. A., Shivers R. R. Heat stress affects blood-brain barrier permeability to horseradish peroxidase in mice. Acta Neuropathalogica. 86:1993;49-54.
43. Zajicek J. Studies on the histogenesis of blood platelets and megakaryocytes. Acta Physiol. Scand. 40:1957;1-32.